The company based in California(CA)reported a risein revenue to $38.63 milion for the year when compared to $29.75 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Feb 9,2023 showed that its revenue is down 29.84% year-over-year.
The company reported basic earnings per share of $-3.71 and diluted earnings per share of $48607990.
Nurix Therapeutics, Inc. operates in the Pharmaceutical Preparations sector.
Related News
